ResMed Inc
Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%
ResMed ClinicalTrials.gov Newly Started Studies by Quarter
ClinicalTrials.gov Newly Started Studies — ResMed
ResMed ClinicalTrials.gov Newly Started Studies: 2 in Q1 FY27, unchanged from a year earlier.
Where the Q1 FY27 figure comes from
Source: NIH ClinicalTrials.gov Registry — ResMed ↗
Reported in NIH ClinicalTrials.gov API v2 (166 Lead-Sponsor ResMed Studies).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up clinicalTrials.gov Newly Started Studies
Cite this data
StockData. (2026). ResMed ClinicalTrials.gov Newly Started Studies, quarterly Q3 FY16–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/ext-ct-started
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?